Royalty Pharma
RPRX
$27.41
Share price
3.87%
Change (1 day)
-17.37%
Change (1 year)
Categories
Earnings for Royalty Pharma (RPRX)
Earnings in 2023 (TTM): $1.88 B
According to Royalty Pharma's latest financial reports the company's current earnings (TTM) are $1.37 B. In 2022 the company made an earning of $0.41 B a decrease over its 2021 earnings that were of $1.40 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Royalty Pharma from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $1.88 B | 351.47% |
| 2022 | $0.41 B | -70.3% |
| 2021 | $1.40 B | -24.3% |
| 2020 | $1.85 B | -31.9% |
| 2019 | $2.72 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $6.53 B | 376.81% | 🇺🇸 USA |
 Eli Lilly LLY | $7.56 B | 451.41% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $43.04 M | -96.86% | 🇺🇸 USA |